title: Neurocutaneous Syndromes and Brain Tumors.
abstract: The etiology of most childhood cancer remains largely unknown, but is likely attributable to random or induced genetic aberrations in somatic tissue. However, a subset of children develops cancer in the setting of an underlying inheritable condition involving a germline genetic mutation or chromosomal aberration. The term "neurocutaneous syndrome" encompasses a group of multisystem, hereditary disorders that are associated with skin manifestations as well as central and/or peripheral nervous system lesions of variable severity. This review outlines the central nervous system tumors associated with underlying neurocutaneous disorders, including neurofibromatosis type 1, neurofibromatosis type 2, schwannomatosis, tuberous sclerosis complex, Von Hippel Lindau, and nevoid basal cell carcinoma syndrome. Recognizing the presence of an underlying syndrome is critically important to both optimizing clinical care and treatment as well as genetic counseling and monitoring of these affected patients and their families.
authors.affiliation: Department of Neurology, Boston Children's Hospital and Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA nicole.ullrich@childrens.harvard.edu.
authors.forename: Nicole J
authors.initials: NJ
authors.lastname: Ullrich
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D002648:Child; D006801:Humans; D020752:Neurocutaneous Syndromes / Q000150:complications* / Q000175:diagnosis / Q000235:genetics / Q000628:therapy
keywords: brain tumor; cancer; children; genetic susceptibility; neurocutaneous syndrome